Overview

Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)

Status:
Completed
Trial end date:
2003-12-22
Target enrollment:
Participant gender:
Summary
A clinical study to determine the efficacy and safety of an investigational medication (MK0869) in the treatment of depression.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Aprepitant
Fosaprepitant